Position in PFE
as of Jun 30, 2026
· filed Jul 23, 2026
Position Value
$589,140
-$74,249 QoQ
Shares Held
24,466
+3.6% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.17%
of 13F equity value
Holder Rank
#1,640
of 2,821 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 82%
Shared 11%
None 6%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Essex Bank holds $41,161,477 across 11 Drug Manufacturers - General names. PFE ranks #8 (1.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
67,809 | $17,221,451 | |
| 2 | LLY |
ELI LILLY & Co
|
10,367 | $12,434,490 | |
| 3 | MRK |
Merck & Co., Inc.
|
28,245 | $3,629,482 | |
| 4 | ABBV |
AbbVie Inc.
|
13,631 | $3,430,104 | |
| 5 | AMGN |
Amgen Inc
|
2,520 | $912,541 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
13,528 | $779,482 | |
| 7 | NVS |
Novartis AG
|
4,797 | $751,785 | |
| 8 | PFE |
Pfizer Inc
This page
|
24,466 | $589,140 |
All Filings in PFE
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $589,140 | 24,466 | Shares | Sole | 2026-07-23 | |
| 2026-03-31 | $663,389 | 23,625 | Shares | Sole | 2026-04-17 | |
| 2025-12-31 | $587,514 | 23,595 | Shares | Sole | 2026-02-02 | |
| 2025-09-30 | $712,700 | 27,971 | Shares | Sole | 2025-11-04 | |
| 2025-06-30 | $803,022 | 33,128 | Shares | Sole | 2025-07-11 | |
| 2025-03-31 | $925,314 | 36,516 | Shares | Sole | 2025-04-21 | |
| 2024-12-31 | $1,081,548 | 40,767 | Shares | Sole | 2025-01-14 | |
| 2024-09-30 | $1,420,953 | 49,100 | Shares | Sole | 2024-11-01 | |
| 2024-06-30 | $1,410,191 | 50,400 | Shares | Sole | 2024-07-23 | |
| 2024-03-31 | $1,506,297 | 54,281 | Shares | Sole | 2024-04-22 | |
| 2023-12-31 | $1,562,749 | 54,281 | Shares | Sole | 2024-01-22 | |
| 2023-09-30 | $1,717,375 | 51,775 | Shares | Sole | 2023-10-12 | |
| 2023-06-30 | $2,071,575 | 56,477 | Shares | Defined | 2023-07-19 | |
| 2023-03-31 | $2,243,305 | 54,983 | Shares | Sole | 2023-04-24 | |
| 2022-12-31 | $2,608,423 | 50,906 | Shares | Sole | 2023-01-18 | |
| 2022-09-30 | $2,183,667 | 49,901 | Shares | Sole | 2022-10-19 | |
| 2022-06-30 | $2,684,520 | 51,202 | Shares | Sole | 2022-07-19 | |
| 2022-03-31 | $2,656,215 | 51,308 | Shares | Sole | 2022-05-03 | |
| 2021-12-31 | $2,963,246 | 50,182 | Shares | Sole | 2022-02-23 | |
| 2021-09-30 | $2,178,800 | 50,658 | Shares | Sole | 2021-10-20 | |
| 2021-06-30 | $1,939,046 | 49,516 | Shares | Sole | 2021-07-29 | |
| 2021-03-31 | $1,827,984 | 50,455 | Shares | Sole | 2021-04-22 | |
| 2020-12-31 | $2,193,396 | 59,587 | Shares | Sole | 2021-02-03 | |
| 2020-09-30 | $2,505,763 | 68,277 | Shares | Sole | 2020-10-26 | |
| 2020-06-30 | $2,134,625 | 65,279 | Shares | Sole | 2020-07-30 | |
| 2020-03-31 | $2,157,500 | 66,100 | Shares | Sole | 2020-04-28 | |
| No filing history on record for this holder in this stock. | ||||||